vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $70.6M, roughly 1.1× MEDALLION FINANCIAL CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 25.4%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 15.0%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
MFIN vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $75.5M |
| Net Profit | $12.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 29.3% | 22.7% |
| Net Margin | 17.3% | — |
| Revenue YoY | 25.4% | 27.7% |
| Net Profit YoY | 20.3% | — |
| EPS (diluted) | $0.50 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.6M | $75.5M | ||
| Q3 25 | $58.7M | $54.5M | ||
| Q2 25 | $62.6M | $52.4M | ||
| Q1 25 | $63.0M | $46.0M | ||
| Q4 24 | $56.3M | $59.1M | ||
| Q3 24 | $53.3M | $80.5M | ||
| Q2 24 | $51.0M | $47.1M | ||
| Q1 24 | $53.3M | $43.8M |
| Q4 25 | $12.2M | — | ||
| Q3 25 | $7.8M | $8.8M | ||
| Q2 25 | $11.1M | $5.9M | ||
| Q1 25 | $12.0M | $3.0M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $8.6M | $20.3M | ||
| Q2 24 | $7.1M | $-4.5M | ||
| Q1 24 | $10.0M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 29.3% | 22.7% | ||
| Q3 25 | 33.2% | 17.6% | ||
| Q2 25 | 31.1% | 12.7% | ||
| Q1 25 | 32.1% | 8.7% | ||
| Q4 24 | 32.8% | 22.6% | ||
| Q3 24 | 26.6% | 27.4% | ||
| Q2 24 | 24.3% | -4.6% | ||
| Q1 24 | 33.6% | -5.3% |
| Q4 25 | 17.3% | — | ||
| Q3 25 | 13.2% | 16.2% | ||
| Q2 25 | 17.7% | 11.2% | ||
| Q1 25 | 19.1% | 6.5% | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 16.1% | 25.2% | ||
| Q2 24 | 13.9% | -9.6% | ||
| Q1 24 | 18.8% | -11.0% |
| Q4 25 | $0.50 | $0.26 | ||
| Q3 25 | $0.32 | $0.17 | ||
| Q2 25 | $0.46 | $0.12 | ||
| Q1 25 | $0.50 | $0.06 | ||
| Q4 24 | $0.43 | $0.40 | ||
| Q3 24 | $0.37 | $0.41 | ||
| Q2 24 | $0.30 | $-0.09 | ||
| Q1 24 | $0.42 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $97.5M |
| Total DebtLower is stronger | $216.0M | $22.7M |
| Stockholders' EquityBook value | $408.6M | $130.3M |
| Total Assets | $3.0B | $216.3M |
| Debt / EquityLower = less leverage | 0.53× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.3M | $97.5M | ||
| Q3 25 | $72.5M | $94.4M | ||
| Q2 25 | $110.4M | $96.0M | ||
| Q1 25 | $131.5M | $93.2M | ||
| Q4 24 | $98.2M | $101.0M | ||
| Q3 24 | $120.6M | $96.7M | ||
| Q2 24 | $87.7M | $96.8M | ||
| Q1 24 | $54.8M | $107.2M |
| Q4 25 | $216.0M | $22.7M | ||
| Q3 25 | $215.7M | $34.0M | ||
| Q2 25 | $199.9M | $45.3M | ||
| Q1 25 | $199.7M | $56.7M | ||
| Q4 24 | $232.2M | $68.0M | ||
| Q3 24 | $232.0M | $79.3M | ||
| Q2 24 | $230.8M | $90.7M | ||
| Q1 24 | $225.6M | $102.0M |
| Q4 25 | $408.6M | $130.3M | ||
| Q3 25 | $397.4M | $115.3M | ||
| Q2 25 | $389.9M | $104.7M | ||
| Q1 25 | $380.2M | $97.1M | ||
| Q4 24 | $370.2M | $92.1M | ||
| Q3 24 | $362.4M | $71.1M | ||
| Q2 24 | $354.0M | $48.5M | ||
| Q1 24 | $349.0M | $51.0M |
| Q4 25 | $3.0B | $216.3M | ||
| Q3 25 | $2.9B | $202.9M | ||
| Q2 25 | $2.9B | $194.9M | ||
| Q1 25 | $2.8B | $196.2M | ||
| Q4 24 | $2.9B | $213.3M | ||
| Q3 24 | $2.9B | $220.7M | ||
| Q2 24 | $2.8B | $205.0M | ||
| Q1 24 | $2.6B | $214.1M |
| Q4 25 | 0.53× | 0.17× | ||
| Q3 25 | 0.54× | 0.30× | ||
| Q2 25 | 0.51× | 0.43× | ||
| Q1 25 | 0.53× | 0.58× | ||
| Q4 24 | 0.63× | 0.74× | ||
| Q3 24 | 0.64× | 1.12× | ||
| Q2 24 | 0.65× | 1.87× | ||
| Q1 24 | 0.65× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 10.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $14.4M | ||
| Q3 25 | $67.0M | $9.7M | ||
| Q2 25 | $-10.7M | $14.1M | ||
| Q1 25 | $36.3M | $3.6M | ||
| Q4 24 | $108.7M | $15.6M | ||
| Q3 24 | $24.6M | $11.0M | ||
| Q2 24 | $27.6M | $1.0M | ||
| Q1 24 | $32.3M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 10.35× | — | ||
| Q3 25 | 8.63× | 1.10× | ||
| Q2 25 | -0.97× | 2.41× | ||
| Q1 25 | 3.02× | 1.21× | ||
| Q4 24 | 10.72× | — | ||
| Q3 24 | 2.86× | 0.54× | ||
| Q2 24 | 3.89× | — | ||
| Q1 24 | 3.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
